• Vimian appointed Hans Lord Skarplöth as head of Specialty Pharma, joining the group management team from Oct. 1, 2026.
• Skarplöth previously served 13 years as CEO of ATG, leading a transformation focused on market position, international expansion, new launches.
• He earlier held senior leadership roles within the Kinnevik sphere for more than seven years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vimian Group AB published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.